You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

KETOPROFEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Ketoprofen

A generic version of KETOPROFEN was approved as ketoprofen by TEVA on December 22nd, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for KETOPROFEN?
  • What are the global sales for KETOPROFEN?
  • What is Average Wholesale Price for KETOPROFEN?
Drug patent expirations by year for KETOPROFEN
Drug Prices for KETOPROFEN

See drug prices for KETOPROFEN

Drug Sales Revenue Trends for KETOPROFEN

See drug sales revenues for KETOPROFEN

Recent Clinical Trials for KETOPROFEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of IowaPhase 4
Gustavo Avila-Ortiz DDS, MS, PhDPhase 4
Osteology FoundationPhase 4

See all KETOPROFEN clinical trials

Pharmacology for KETOPROFEN
Medical Subject Heading (MeSH) Categories for KETOPROFEN

US Patents and Regulatory Information for KETOPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075270-002 Mar 24, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo KETOPROFEN ketoprofen TABLET;ORAL 075364-001 Feb 7, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075679-001 Feb 20, 2002 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alkermes Gainesville KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 074879-001 Dec 10, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising KETOPROFEN ketoprofen CAPSULE;ORAL 074035-002 Dec 31, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.